Skip to content

Nuvalent, Inc. NUVL Total Equity

Total Equity at other companies

Pfizer logo
PfizerPFE
$90.1B-0.3%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$545.93M+58.5%
Exelixis logo
ExelixisEXEL
$1.94B-9.2%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$1.5B-27.8%
Incyte logo
IncyteINCY
$5.62B+53.3%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s total equity?
Nuvalent, Inc. (NUVL) reported total equity of $1.17B in Q1 2026.
How has Nuvalent, Inc.'s total equity changed year-over-year?
Nuvalent, Inc.'s total equity increased by 16.2% year-over-year, from $1.01B to $1.17B.
What is the long-term trend for Nuvalent, Inc.'s total equity?
Over 5 years (2020 to 2025), Nuvalent, Inc.'s total equity has grown at a 109.0% compound annual growth rate (CAGR), from -$31.32M to $1.25B.
What does total equity mean?
The total value of the company that belongs to the shareholders after all debts are paid.
How do you interpret total equity?
An increase indicates capital raises or positive earnings, while a decrease suggests losses or capital distributions.
How does total equity compare across companies?
Essential for assessing the 'runway' of biotech companies relative to their cash burn.